Skip to content

The Effect of Spirulina Algae on Inflamation Status and Appetite in Obese Individuals

The Effect of Spirulina Platensis Algae Supplementation on Serum Concentration Macrophage Inhibitory Cytokine (MIC-1), Superoxide Dismutase (SOD) and Glutathione Peroxidase (GPX) and Appetite in Obese Individuals

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015071619082N8
Enrollment
64
Registered
2015-09-30
Start date
2015-10-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OBESITY. Obesity, Unspecified

Interventions

Intervention 1: Supplement group: Spirulina Platensis Algae supplement 500 mg, 2 tablets a day, during 12 weeks of intervention. Intervention 2: Placebo: The same az supplement in appearance, without
Treatment - Other
Treatment - Drugs
Supplement group: Spirulina Platensis Algae supplement 500 mg, 2 tablets a day, during 12 weeks of intervention.
Placebo: The same az supplement in appearance, without chlorophyl, 500 mg, 2 tablets a day, during 12 weeks of intervention.

Sponsors

Tabriz University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Tendency to attend the trial; BMI in the range of 30-39 kg/m2; age limit between 20 and 50 of years. Exclusion criteria: History of GI disease, diabetes, infections, cancers and drug therapy; consumption of any antioxidant multi-vitamins, fiber and Omega 3 supplements 3 months before and during the trial; pregnancy and breast feeding; menopause; following weight loss diets 3 months before and during the trial; history of renal diseases, CVD and recent surgeries; consumption of weight effective drugs (hormones and antidepressant drugs), diuretics, antibiotics; effective drugs on inflammation status.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum Concentrtaion of Macrophage Inhibitory Cytokine-1 (MIC-1). Timepoint: Before the intervention, 3 months after the intervention. Method of measurement: ELISA, pg/ml.;Superoxide Dismutase (SOD) status. Timepoint: Before the intervention, 3 months after the intervention. Method of measurement: Spectrophotometry, U/ml.;Glutathione Peroxidase (GPX) status. Timepoint: Before the intervention, 3 months after the intervention. Method of measurement: Spectrophotometry,Mu/ml.;Anthropometric parameters. Timepoint: Before the intervention, 3 months after the intervention. Method of measurement: Weight, kg; Height, cm.;Appetite. Timepoint: Before the intervention, 3 months after the intervention. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Energy intake, macronutrients. Timepoint: Before the intervention, 3 months after the intervention begins. Method of measurement: Questionnaire.;Physical activity. Timepoint: Before the intervention, 3 months after the intervention begins. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefeh Shariat

Health and Nutrition Faculty of Tabriz University of Medical Science

atefeh_shariat@yahoo.com+98 912 365 4936

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026